The share price of AN2 Therapeutics, Inc. (ANTX) now
What analysts predict: $24
52-week High/Low: $21.04 / $4.87
50/200 Day Moving Average:
$9.58 / $9.46
This figure corresponds to the Average Price over the previous 50/200 days.
For AN2 Therapeutics stocks, the 50-day moving average is the support level today.
For AN2 Therapeutics stocks, the 200-day moving average is the support level today.
Are you interested in AN2 Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio?
If yes, then on this page you will find useful information about the dynamics of the AN2 Therapeutics
stock price in 2023, 2024, 2025, 2026, 2027.
How much will one AN2 Therapeutics share be worth in
2023 - 2027?
When should I take profit in AN2 Therapeutics stock?
When should I record a loss on AN2 Therapeutics stock?
What are analysts' forecasts for AN2 Therapeutics stock?
What is the future of AN2 Therapeutics stock?
We forecast AN2 Therapeutics stock performance using neural networks based on historical data on AN2 Therapeutics stocks.
Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
AN2 Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals.
(Next month, 2023, 2024, 2025, 2026 and 2027)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for AN2 Therapeutics shares. This happens once a day.
Historical and forecast chart of AN2 Therapeutics stock
The chart below shows the historical price of AN2 Therapeutics stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the AN2 Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
Subscribe for Forecasts Update!
AN2 Therapeutics daily forecast for a month
Date
Target
Pes.
Opt.
Vol., %
Oct 02
16.21
15.87
16.47
3.78
Oct 03
16.10
15.91
16.31
2.49
Oct 04
16.27
16.13
16.62
2.99
Oct 05
16.02
15.91
16.35
2.77
Oct 06
15.84
15.61
15.93
2.03
Oct 07
16.11
15.83
16.41
3.65
Oct 08
15.90
15.70
16.15
2.87
Oct 09
16.02
15.67
16.24
3.64
Oct 10
16.34
16.24
16.55
1.90
Oct 11
16.19
16.03
16.41
2.37
Oct 12
15.97
15.87
16.29
2.66
Oct 13
15.95
15.79
16.12
2.10
Oct 14
15.97
15.77
16.16
2.46
Oct 15
15.91
15.67
16.14
3.04
Oct 16
16.23
15.96
16.55
3.71
Oct 17
16.26
16.02
16.37
2.19
Oct 18
16.48
16.33
16.59
1.61
Oct 19
16.55
16.44
16.78
2.07
Oct 20
16.54
16.37
16.88
3.14
Oct 21
16.50
16.31
16.67
2.16
Oct 22
16.45
16.27
16.68
2.48
Oct 23
16.55
16.36
16.79
2.65
Oct 24
16.65
16.52
16.89
2.20
Oct 25
16.97
16.66
17.28
3.74
Oct 26
17.40
17.24
17.57
1.88
Oct 27
17.74
17.41
18.02
3.49
Oct 28
17.41
17.15
17.61
2.71
Oct 29
17.19
16.82
17.37
3.26
Oct 30
16.86
16.65
16.97
1.94
Oct 31
16.92
16.68
17.16
2.88
AN2 Therapeutics Daily Price Targets
AN2 Therapeutics Stock Forecast 10-02-2023.
Forecast target price for 10-02-2023: $16.21. Positive dynamics for AN2 Therapeutics shares will prevail with possible volatility of 3.640%. Pessimistic target level: 15.87 Optimistic target level: 16.47
AN2 Therapeutics Stock Forecast 10-03-2023.
Forecast target price for 10-03-2023: $16.10. Negative dynamics for AN2 Therapeutics shares will prevail with possible volatility of 2.426%. Pessimistic target level: 15.91 Optimistic target level: 16.31
AN2 Therapeutics Stock Forecast 10-04-2023.
Forecast target price for 10-04-2023: $16.27. Positive dynamics for AN2 Therapeutics shares will prevail with possible volatility of 2.907%. Pessimistic target level: 16.13 Optimistic target level: 16.62
AN2 Therapeutics Stock Forecast 10-05-2023.
Forecast target price for 10-05-2023: $16.02. Negative dynamics for AN2 Therapeutics shares will prevail with possible volatility of 2.697%. Pessimistic target level: 15.91 Optimistic target level: 16.35
AN2 Therapeutics Stock Forecast 10-06-2023.
Forecast target price for 10-06-2023: $15.84. Negative dynamics for AN2 Therapeutics shares will prevail with possible volatility of 1.987%. Pessimistic target level: 15.61 Optimistic target level: 15.93
AN2 Therapeutics Stock Forecast 10-07-2023.
Forecast target price for 10-07-2023: $16.11. Positive dynamics for AN2 Therapeutics shares will prevail with possible volatility of 3.526%. Pessimistic target level: 15.83 Optimistic target level: 16.41
AN2 is developing treatments for rare, chronic, and serious infectious diseases. Its initial product candidate is epetraborole, a once-daily oral drug that aims to treat chronic nontuberculous mycobacterial lung disease.
The biotech is the second company to open for trading in March. The first was Akanda (ticker: AKAN), a medical-cannabis company, which listed its shares on March 15, soaring 163% in its debut. Akanda stock is down about 18% from the $10.50 first-day closing price but still up 116% from the $4 IPO price.
AN2 Therapeutics Address
1800 EL CAMINO REAL, SUITE D, MENLO PARK, CA, US
Market Capitalization:
453 020 000 $
Market capitalization of the AN2 Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula
multiplying the number of ANTX shares in the company outstanding by the market price of one share.
EBITDA:
- $
EBITDA of AN2 Therapeutics is earnings before interest, income tax and depreciation of assets.
PE Ratio:
None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio:
None
Price/earnings to growth
DPS:
N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY:
N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS:
-3.49
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY:
N/A
Quarterly Revenue Growth YOY:
N/A
Trailing PE:
-
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE:
-
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue:
-
Enterprise Value (EV) /Revenue
EV To EBITDA:
-2.338
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding:
29706200
Number of issued ordinary shares
Shares Float:
N/A
Number of freely tradable shares
Shares Short Prior Month:
N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and,
moreover, are not trading signals.
When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market
as a result of using the information contained on the site.
This website uses cookies to ensure you get the best experience on our website